Table 1 Relationship between TACC3 expression and clinicopathological features of patients with PDAC.
Characteristics | The Pooled(N = 218) | TACC3 | P-value | |
|---|---|---|---|---|
Low (N = 104) | High (N = 114) | |||
Age(years) | Â | Â | Â | 0.986 |
≤60 | 90 | 43 | 47 |  |
<60 | 128 | 61 | 67 | Â |
Gender | Â | Â | Â | 0.976 |
Male | 126 | 60 | 66 | Â |
Female | 92 | 44 | 48 | Â |
Tumor location | Â | Â | Â | 0.477 |
Head and neck | 127 | 58 | 69 | Â |
Body and tail | 91 | 46 | 45 | Â |
Neural invasion | Â | Â | Â | 0.039 |
No | 42 | 26 | 16 | Â |
Yes | 172 | 76 | 96 | Â |
Microvascular invasion | Â | Â | 0.013 | |
No | 149 | 80 | 69 | Â |
Yes | 57 | 20 | 37 | Â |
Tumor differentiation | Â | Â | 0.029 | |
Poor | 75 | 32 | 43 | Â |
Moderate | 106 | 47 | 59 | Â |
Well | 37 | 25 | 12 | Â |
8th AJCC stage | Â | Â | Â | 0.005 |
I | 89 | 52 | 37 | Â |
II | 103 | 46 | 57 | Â |
III | 26 | 6 | 20 | Â |
8th T stage | Â | Â | Â | 0.012 |
I | 28 | 20 | 8 | Â |
II | 124 | 59 | 65 | Â |
III | 66 | 25 | 41 | Â |
8th N stage | Â | Â | Â | 0.027 |
0 | 121 | 67 | 54 | Â |
1 | 68 | 28 | 40 | Â |
2 | 29 | 9 | 20 | Â |
Preoperative CA19-9 (U/ml) | Â | Â | 0.042 | |
≤37 | 48 | 29 | 19 |  |
<37 | 169 | 74 | 95 | Â |
Ki-67 | Â | Â | Â | <0.001 |
Low | 93 | 57 | 36 | Â |
High | 77 | 22 | 55 | Â |